•When managing systemic lupus erythematosus in pregnancy, consideration should be given to both safe medication choices and, where anti-Ro/La antibodies are positive, additional fetal monitoring due to the risk of congenital heart block. This evidence concerns the gene SSB and systemic lupus erythematosus.